AlphaFold predicted structure
ADA2 · Q9NZK5

Mean pLDDT
95.8/ 100
Very high
511 residues
Confidence breakdown
- Very high(≥ 90)94%
- Confident(70–90)1%
- Low(50–70)2%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
adenosine deaminase 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Autoinflammatory disorders
BIALLELIC, autosomal or pseudoautosomalCOVID-19 research
BIALLELIC, autosomal or pseudoautosomalCytopenia - NOT Fanconi anaemia
BIALLELIC, autosomal or pseudoautosomalCytopenias and congenital anaemias
BIALLELIC, autosomal or pseudoautosomalHereditary neuropathy or pain disorder
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalRare anaemia
BIALLELIC, autosomal or pseudoautosomalRare genetic inflammatory skin disorders
BIALLELIC, autosomal or pseudoautosomal+1 more panels — install the extension to see the full list inline on any page.
deficiency of adenosine deaminase 2
Sneddon syndrome
polyarteritis nodosa, childhoood-onset
Diamond-Blackfan anemia
Blackfan-Diamond anemia
autoinflammatory syndrome
Behcet disease
Splenomegaly
immunodeficiency disease
polyarteritis nodosa
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Adenosine deaminase 2
Adenosine deaminase that may contribute to the degradation of extracellular adenosine, a signaling molecule that controls a variety of cellular responses. Requires elevated adenosine levels for optimal enzyme activity. Binds to cell surfaces via proteoglycans and may play a role in the regulation of cell proliferation and differentiation, independently of its enzyme activity
ADA2 · Q9NZK5

Mean pLDDT
95.8/ 100
Very high
511 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0